W. Patrick Walters, Ph.D., Senior Research Fellow, Group Head, Computational Drug Discovery Technologies, Vertex Pharmaceuticals, Inc.
Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design
Gergely Toth, Ph.D., University of Cambridge, UK
David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD Pharmaceuticals, Inc.
José Duca, Ph.D., Senior Principal Scientist, 3D - Drug Design Department, Merck Research Laboratories
Raymond C. Stevens, Ph.D., Professor, Departments of Molecular Biology and Chemistry, Scripps Research Institute
D. R. Artis, Ph.D., Senior Vice President, Global Research, Elan Pharmaceuticals, Inc.
Talapady Bhat, Ph.D., Project Leader, Biochemical Science, NIST
Natasja Brooijmans, Ph.D., Principal Research Scientist, Computational Chemistry & Cheminformatics, Pfizer, Inc.
Stefano Costanzi, Ph.D., Head of the Molecular Modeling Unit, Laboratory Biological Modeling, NIDDK, National Institutes of Health
David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD Pharmaceuticals, Inc.
Rajarshi Guha, Ph.D., Research Scientist, Informatics, NIH Chemical Genomics Center
Michael Hanson, Ph.D., Associate Director, Structural Biology, Receptos, Inc.
Roderick Hubbard, Ph.D., Professor and Senior Fellow, Structural Sciences, University of York and Vernalis
Rama Kondru, Ph.D., Principal Research Scientist, Discovery Chemistry, Hoffmann-La Roche
Andreas Kuglstatter, Ph.D., Research Scientist, Discovery Technologies, Roche
- Ryan Lilien, Ph.D., M.D., Assistant Professor, Department of Computer Science and Banting & Best Department of Medical Research, Faculty of Medicine, University of Toronto
- Jody Mason, Ph.D., Lecturer, Biological Sciences, University of Essex
Jonathan Mason, Ph.D., Head of Computational Chemistry / Chief Scientist, Medicinal Chemistry, Heptares Therapeutic Ltd / Lundbeck Resesrch DK
Nicolas Moitessier, Ph.D., Professor, Chemistry, McGill University
Xavier Morelli, Ph.D., Group Leader, Drug Design, CNRS/ IMR Laboratory
Paul Mortenson, Ph.D., Senior Research Associate, Computational Chemistry and Informatics, Astex Therapeutics Ltd.
Deqiang Niu, Ph.D., Principal Scientist/Project Leader, Medicinal Chemistry, Avila Therapeutics
Emanuele Perola, Ph.D., Research Fellow, Computational Drug Discovery Technologies, Vertex Pharmaceuticals, Inc.
Matthias Rarey, Ph.D., Professor & Managing Director, ZBH Center for Bioinformatics, University of Hamburg
Alan Rigby, Ph.D., Assistant Professor of Medicine, Harvard Medical School; Director, Program in Drug Discovery and Target Validation, Beth Israel Deaconess Medical Center
Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design
Celia Schiffer, Ph.D., Professor, Biochemistry & Molecular Pharmacology, UMass Medical School
Woody Sherman, Ph.D., Vice President, Applications Science, Schrodinger, Inc.
Juswinder Singh, Ph.D., Co-Founder/Chief Scientific Officer, Avila Therapeutics
Sid Topiol, Ph.D., Head of US Computational Chemistry and Structural Investigations, Lundbeck Research, USA
Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group (CCG)
Jeffrey S. Wiseman, Ph.D., CEO and Co-Founder, Pharmatrope, Ltd.
Jie Zheng, Ph.D., Associate Member, Department of Structural Biology, St. Jude Children's Research Hospital